Since Morphic Medical’s founding in 2003, our mission has been to alleviate the symptoms of type 2 diabetes and obesity for patients fighting these global epidemics worldwide. Our revolutionary RESET® therapy is a testament to Morphic Medical’s mission. The first endoscopically delivered device therapy for the treatment of type 2 diabetes and obesity. Morphic Medical’s aim is to bridge the gap between pharmaceuticals and surgery by providing an alternate treatment option to help reduce HbA1c and weight for individuals who are underserved by drugs and injections, but for whom surgery may not be an option.
Morphic Medical is headquartered in Boston, Massachusetts. Our team of business experts and industry veterans have a successful track record of pioneering and commercializing breakthrough healthcare technologies.